ArticleBMC musculoskeletal disorders2025
Finegoldia magna infection after lumbar spine surgery determined based on targeted next-generation sequencing.
Article in BMC musculoskeletal disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Detection ofInfection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionFacultative anaerobic bacteria are the predominant pathogens in postoperative lumbar spine infections, while gram-positive anaerobic cocci, such as Finegoldia magna (F. magna), act as opportunistic pathogens and are among the most virulent. We report an elderly woman who suffered Finegoldia infection after lumbar spine surgery. To the best of our knowledge, this is the first well-documented case in the literature. CASE DESCRIPTION: A 67-year-old female underwent a multi-segmental posterior lumbar interbody fusion surgery for lumbar spinal stenosis. On postoperative day 11, central surgical incision dehiscence was noted, accompanied by wound discharge and lumbar-hip pain. Wound secretions were cultured four times and all tested negative for bacteria. The causative agent was identified as F. magna via targeted next-generation sequencing (tNGS) combined with traditional microbial smear microscopy. After 4 days of piperacillin-tazobactam, the patient developed persistent high fever (39.5℃), prompting a cautious switch to combination therapy with vancomycin and metronidazole, which resolved the infection effectively.
conclusionF. magna is an uncommon cause of post-lumbar spine surgery infection, warranting a high index of suspicion for this gram-positive anaerobic coccus. When F. magna infection is encountered, treatment with vancomycin or metronidazole may be considered when antimicrobial susceptibility testing is not available.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.